This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
This groundbreaking drug enters clinical trials in 2024 and is scheduled to be available to consumers by 2030.
